Rectal Cancer

Research

Mayo Clinic is a leader in developing colorectal cancer screening procedures and investigating new drugs or combinations of drugs to prevent the spread or recurrence of cancer. Mayo is a member of the Alliance for Clinical Trials in Oncology, a national clinical research group that conducts top-quality trials aimed at controlling, treating and preventing cancer. Areas of research include:

• New diagnostic approaches, such as testing DNA in the stool
• New treatments, such as combination therapies
• Environmental and genetic risk factors
• New clinical pathways for molecular testing to identify people with young-onset colorectal cancer syndrome
• Testing the effectiveness and safety of new technology for minimally invasive surgical procedures for colorectal cancer
• Measurement of quality of life after surgery for colorectal cancer
• Early recognition of young-onset colorectal cancer to improve outcomes

Publications

See a list of publications by Mayo doctors on rectal cancer on PubMed, a service of the National Library of Medicine.